Fernandes Tavora Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00329680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (4)

gamolenic acid (1 trial)

icosapent ethyl (vascepa) (1 trial)

multivitamins (1 trial)

olive oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sepsis (Phase 4)

Shock, Septic (Phase 4)

Toxemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4